Elisa Meddi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial.
Journal: American journal of hematology
Published: May 25, 2026
De novo JAK2-mutated acute myeloid leukaemia: Clinical outcomes and molecular features.
Journal: British journal of haematology
Published: April 23, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.
Journal: Cancers
Published: December 28, 2025
Measurable residual disease as an actionable biomarker in acute myeloid leukemia. Ready or not?
Journal: Current opinion in oncology
Published: October 01, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.
Journal: Cancers
Published: May 13, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response.
Journal: Journal of clinical medicine
Published: January 28, 2025
Culprit or innocent bystander? The case of a new fast-moving hemoglobin J variant in a pregnant woman.
Journal: Blood cells, molecules & diseases
Published: January 18, 2025
Leukemia Cutis in a Patient with Acute Myeloid Leukemia Undergoing Azacitidine-Venetoclax: Case Presentation and Review of the Literature.
Journal: Mediterranean journal of hematology and infectious diseases
Published: December 05, 2024
Last Updated: 09/26/2026